Xiaoqiang Yan, Ph.D.

More than 24 years of biopharmaceutical industry experience in new drug discovery & development, with a therapeutic focus on Hematology, Oncology, Inflammation, Metabolic diseases and Aging-related diseases
More than 100 granted patents and >30 pending patent applications as co-inventor and with > 30 publications as co-author
Former Chief Scientific Officer, Generon Corporation Ltd.
Vice President, Research & Technology, Hutchison Medipharma Ltd. Shanghai, China
Research Scientist, Department of Function Genomics, Pharmacology & Pathology, and Experimental Hematology, Amgen Inc. USA
Ph.D. in Molecular & Cellular Biology, University of Toronto, Canada
M. Med., West China University of Medicine, Sichuan, China
B. Med., Sichuan Medical College, Sichuan, China
Xinfeng Zhang, Ph.D.
Vice President
Head of Global CMC Operation

Joined Generon in 2012 to lead development and manufacturing of Fc Fusion proteins; Experienced with CMC development, commercialization, "Quality by Design" and lifecycle management of biopharmaceuticals
Associate Director, Process Science, Boehringer Ingelheim, Fremont, CA, USA
Vectibix (panitumumb) Global Analytical Lead, Process and Product Engineering, Amgen, Fremont, CA, USA
Scientist II, Process and Development, PDL Biopharma. Fremont, CA, USA
Scientist, Process and Product Development, Novartis (Chiron), Emeryville, CA, USA
Ph.D. in Chemistry, University of Rhode Island, RI, USA
B. Sc. in Chemistry, Peking University, China
Yumin Cui, Ph.D.
Vice President
Preclinical Research

More than 14 years of new drug discovery experience in the biopharmaceutical industry, focusing on oncology drug discovery and preclinical development with over 20 drug candidates (small molecule drugs and biologics) and 15 publications
Exec. VP. Head of Biology, Shanghai Haiyan Pharma. (Yangtze Pharma Group), Shanghai, China
Director, Oncology, Hutchison Medipharma Ltd. Shanghai, China
Postdoct. Health Science Center, University of Texas, and UCLA, Davis, USA
Ph.D. (M.Sc./B.Sc.) in Biochemistry Engineering, East China University of Science & Technology, Shanghai, China
Bo Qi, M.Sc.
Vice President
Head of CMC
General Manager Generon Beijing

More than 25 years of experience throughout the biologic drug development cycle with successful launches of multiple commercial products; managing multiple downstream groups including process development, analytical support and pilot plant; including leadership roles in process development, process validation and regulatory filing
Director, CMC Development, Eli Lilly, USA
Director, Process Development, ImClone Systems, USA
Associate Scientist, Process Development, Amgen Inc., USA
M.Sc. in Biochemistry, University of Minnesota, USA
B.Sc. in Bioengineering, East China University of Science and Technology, Shanghai, China
Zaiqing Wen, Ph.D.
Vice President
Shanghai CMC Operation

More than 18 years of biopharmaceutical development experience with over 65 papers published and three-time winner of the Frederick D. Simon award from the PDA Society (2010, 2011 and 2014)
Principal Scientist and Analytical Lab Head at Amgen, involved with multiple products¨ development and commercialization
Research Instructor in the Department of Cell Biology and Biophysics at the University of Missouri, Kansas City, USA
JSPS scholar to the Japan Protein Research Institute, Osaka, Japan
Ph.D. in Physical Chemistry, The University of Glasgow, U.K.
B.Sc. in Chemical Physics, The University of Science and Technology of China, China
Gary He, M.Sc. CQA
Vice President
CMC Global Compliance

26 years of leadership experience in GMP compliance, quality system, manufacturing, validation, control strategies, regulatory audits, sterility assurance, process improvement, EH&S and project management, with direct contributions to marketing approval and lifecycle management of multiple monoclonal antibody products
Associate Director, Validation Technical Services, Elli Lilly, USA
M.Sc. in Chemical Engineering, Wayne State University, USA
B.Sc. in Biochemical Engineering at East China University of Science and Technologies
Stewart Leung, Ph.D.
Vice President
Research and Technology

More than 19 years of biopharmaceutical industry experience leading and managing drug discovery and development programs including antibody and small molecule programs
Director of Biology, GSK R&D China
Senior Scientist, Bayer
Research Scientist, Berlex (a subsidiary of Schering AG)
Postdoctoral fellow in Cleveland Clinic Foundation and Tularik
Ph.D. and M.Sc. in Medical Biophysics, University of Toronto, Canada
B.Sc. in microbiology and immunology, University of Western Ontario Honor
Zongshu Xian, M.Sc.
Vice President
Technical operation

22 years of experience in technology development focusing on process establishment, quality control and commercialization scale manufacturing
Completed research and development of more than 10 new drugs, 6 of which developed to commercial production
Project development director, Shanghai Kehua Bio-engineering Co., Ltd., China
Technical Director, Shanghai Hua Xin Biotechnology Co., Ltd., China
Senior Technical Director and Deputy General Manager, Bio-Cancer Treatment International Ltd., China
M.Sc. in Biochemistry, East China Normal University, Shanghai, China
Kenneth Kang, Ph.D.
Vice President

Over 18-years of in-depth experience in biopharmaceutical industry with a focus in process development and characterization, technology transfer, and CMO management; A leader in the biotech industry, promoting new process technologies and chairing multiple international bioprocess conferences; Published 16 articles including 2 journal cover articles; Filed 6 patents
Director of Process Development at Patheon (a subsidiary of Thermo Fisher Scientific), USA
Senior Scientist II at Pfizer (Wyeth), Investigator at Progenics, and Principal Scientist at Eli Lilly, USA
Ph.D., in Chemical Engineering (Bioseperation), New Jersey Institute of Technology, USA
M.Sc. in Chemical Engineering (Biological Reaction Engineering), Zhejiang University, Hangzhou, China
B.Sc. in Chemical engineering, Chengdu University of Science and Technology, Chengdu, China